 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung
|
|
|
|
Phase II, Phase I
|
|
|
|
TR02-2421
NCT00102531
|
|
| |
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
A4021020
NCT00560235
|
|
| |
Peripheral Stem Cell Transplant and White Blood Cell Transfusions in Treating Patients With Refractory Metastatic Solid Tumors
|
|
|
|
Phase II
|
|
|
|
NHLBI-99-H-0064
NCT00003839
|
|
| |
Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
|
|
|
|
Phase II
|
|
|
|
COG-AOST0221
AOST0221, NCT00066365
|
|
| |
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
|
|
|
|
Phase II
|
|
|
|
SARC003
NCT00073983, NCI-04-C-0001, AEWS0421, MAYO-79-2003
|
|
| |
Samarium Sm 153 Lexidronam Pentasodium and Autologous Stem Cell Transplant Followed By Radiation Therapy in Treating Patients With Recurrent or Refractory, Metastatic, or Unresectable Osteosarcoma
|
|
|
|
Phase II
|
|
|
|
JHOC-J0347
JHOC-03090802, NCT00245011
|
|
| |
Radiation Therapy to Treat Musculoskeletal Tumors
|
|
|
|
Phase II
|
|
|
|
RTSARC
NCT00186992
|
|
| |
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer
|
|
|
|
Phase II
|
|
|
|
DFCI-04343
NCT00357500
|
|
| |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
|
|
|
|
Phase II
|
|
|
|
MSKCC-05122
NCT00445965
|
|
| |
Pemetrexed Disodium in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
|
|
|
|
Phase II
|
|
|
|
COG-ADVL0525
ADVL0525, NCT00459147
|
|
